Leadership Overview
Tolmar has 6 executives leading key functions including strategy, finance, medical affairs, operations, legal, and commercialization.
Driven by innovation, Tolmar is a fully integrated pharmaceutical company dedicated to the development, manufacturing, and commercialization of specialty pharmaceuticals, with a significant focus on Urology, impacting global health outcomes.
Driven by innovation, Tolmar is a fully integrated pharmaceutical company dedicated to the development, manufacturing, and commercialization of specialty pharmaceuticals, with a significant focus on Urology, impacting global health outcomes.
Leadership Roles at Tolmar
Anil D'Souza - Chief Executive Officer
Anil D'Souza, the Chief Executive Officer at Tolmar, directs the company's overall strategy and operational execution. D'Souza guides the integrated approach to pharmaceutical development, manufacturing, and commercialization across multiple therapeutic areas, with a specific emphasis on Urology. Overseeing global operations from Northern Colorado, D'Souza ensures alignment with market demands and regulatory standards. This leadership role involves fostering innovation in product development and driving commercial success. By optimizing resource allocation and strategic partnerships, Anil D'Souza advances Tolmar's mission to deliver high-quality specialty pharmaceuticals. The Chief Executive Officer's vision shapes the company's trajectory in a competitive landscape.
Jeff Lederman - Chief Financial Officer
Jeff Lederman, the Chief Financial Officer at Tolmar, manages all financial operations and strategic financial planning. Lederman oversees budgeting, forecasting, and capital allocation to support the company's growth in specialty pharmaceuticals, particularly within the Urology sector. Based in Northern Colorado, the Chief Financial Officer ensures fiscal responsibility across global headquarters and manufacturing facilities. This position involves managing investor relations and securing funding for product development and commercialization initiatives. By optimizing financial performance and mitigating risk, Jeff Lederman contributes directly to Tolmar's sustained market presence. The Chief Financial Officer's expertise is critical for navigating the complex financial landscape of the pharmaceutical industry.
Shawn Silvestri - President & Chief Operating Officer
Shawn Silvestri, the President & Chief Operating Officer at Tolmar, directs day-to-day operations and oversees the company's manufacturing and product development functions. Silvestri ensures the efficient execution of Tolmar's integrated pharmaceutical strategy, from research and development to commercialization, particularly in Urology. Based at the Northern Colorado facilities, the President & Chief Operating Officer manages production, supply chain logistics, and quality control to meet global demand. This critical role involves optimizing operational workflows and driving efficiency across all manufacturing sites. By enhancing operational capabilities, Shawn Silvestri supports the consistent delivery of high-quality specialty pharmaceuticals. The President & Chief Operating Officer's leadership is fundamental to Tolmar's production excellence.
Steve Griffin - President, North America
Steve Griffin, the President, North America at Tolmar, leads the commercial operations and market strategy for the North American region. Griffin drives the sales, marketing, and distribution of Tolmar's specialty pharmaceuticals, with a key focus on expanding the Urology portfolio. Based at the North America commercial headquarters in Buffalo Grove, Illinois, the President, North America ensures regional business objectives align with global company goals. This executive role involves building strong relationships with healthcare providers and stakeholders across the United States and Canada. By optimizing regional commercial performance, Steve Griffin significantly contributes to Tolmar's overall market growth and patient reach. The President, North America's leadership is pivotal for regional success.
Anjan Chatterjee - Chief Medical Officer & Chief Marketing Officer
Anjan Chatterjee, the Chief Medical Officer & Chief Marketing Officer at Tolmar, leads both clinical development and market strategy. Chatterjee oversees the medical affairs and ensures the efficacy and safety of specialty pharmaceuticals, with a deep focus on Urology. Simultaneously, this executive drives market penetration and commercialization efforts, translating scientific advancements into market success. Operating from Northern Colorado, the Chief Medical Officer & Chief Marketing Officer bridges the gap between product innovation and patient access. This dual role requires a comprehensive understanding of therapeutic areas and market dynamics. By aligning medical insights with marketing initiatives, Anjan Chatterjee enhances Tolmar's brand value and therapeutic impact.
Michael Elm - Chief Legal Officer
Michael Elm, the Chief Legal Officer at Tolmar, provides strategic legal counsel and oversees all legal affairs for the company. Elm ensures compliance with regulatory requirements across the development, manufacturing, and commercialization of specialty pharmaceuticals, including those in Urology. Operating from Northern Colorado, the Chief Legal Officer manages intellectual property, corporate governance, and risk mitigation strategies. This position is vital for navigating the complex legal landscape of the pharmaceutical industry. By safeguarding the company's legal interests and ensuring adherence to global standards, Michael Elm supports Tolmar's ethical operations and market integrity. The Chief Legal Officer's guidance is essential for sustained business operations.
Explore Leadership Teams in Manufacturing
Founded in 1907 and headquartered in Vadodara, India, Alembic Limited is an integrated pharmaceutical company. The Company's products include active pharmaceutical ingredients, bulk pharmaceuticals, international and domestic formulations, herbals and nutraceuticals, and veterinary.
Company Leadership EP
WQ
PY
JM
Amrutanjan Health Care Ltd specializes in pain and congestion management products, including aromatic balms, roll-ons, and sprays. Founded in 1893, the company is dedicated to enhancing people's well-being by combining natural extracts with scientific research to create effective, side-effect-free solutions. Their product range caters to various needs, including headache relief, body pain management, and women's hygiene. Amrutanjan aims to serve a global consumer base while maintaining a commitment to sustainability and health.
Company Leadership PD
MB
TJ
JC
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segments products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing,...
Company Leadership CD
DK
KB
Daewoong Pharmaceutical Co., Ltd. is a leading South Korean pharmaceutical company that develops, manufactures, and commercializes pharmaceuticals for both domestic and international markets. With its strong and competent in-house R&D and qualified manufacturing facilities (cGMP), Daewoong provides a total healthcare solution to customers across the globe. Aiming to become a global healthcare company, Daewoong has broadened international operations by establishing branch offices and research centers throughout Asia and the United States. The company was established in 1945 and is headquartered in Seoul, South Korea.
Company Leadership ML
HH
SP
NK
Frequently Asked Questions Regarding Tolmar Top Executives and Leadership Team
Unlock more people and company data
